The Company joins innovation and growth leaders on
Nasdaq
Company's U.S. Ticker symbol to remain "CGC"
SMITHS FALLS, ON, Nov. 3, 2020 /PRNewswire/ - Canopy Growth
Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE:
CGC) announced today it will be transferring its U.S. stock
exchange listing from the New York Stock Exchange to the Nasdaq
Global Select Market effective November 13,
2020 after market close. Common shares of Canopy Growth are
expected to begin trading as a Nasdaq-listed security on
November 16, 2020, with the shares
continuing to trade under the symbol "CGC".
"By making the move over to Nasdaq, we are joining some of the
world's leading companies that share our passion and focus for
innovation," said David Klein,
Canopy Growth CEO. "Making the transition to Nasdaq also provides
us with greater cost-effectiveness and access to a suite of tools
and services that will help us connect more efficiently with our
current and future investors."
Current retail and institutional investor shares will
automatically be transferred over to Nasdaq and current
shareholders are not required to take any action. The last day of
trading of the Company's common stock on NYSE is expected to be
Friday, November 13, 2020.
About Canopy Growth Corporation
Canopy Growth
(TSX:WEED, NYSE:CGC) is a world-leading diversified cannabis, hemp
and cannabis device company, offering distinct brands and curated
cannabis varieties in dried, oil and Softgel capsule forms, as well
as medical devices through Canopy Growth's subsidiary, Storz &
Bickel GMbH & Co. KG. From product and process innovation to
market execution, Canopy Growth is driven by a passion for
leadership and a commitment to building a world-class cannabis
company one product, site and country at a time. Canopy Growth's
medical division, Spectrum Therapeutics is proudly dedicated to
educating healthcare practitioners, conducting robust clinical
research, and furthering the public's understanding of cannabis,
and has devoted millions of dollars toward cutting edge,
commercializable research and IP development. Spectrum Therapeutics
sells a range of full-spectrum products using its colour-coded
classification Spectrum system as well as single cannabinoid
Dronabinol under the brand Bionorica Ethics. Canopy Growth operates
retail stores across Canada under
its award-winning Tweed and Tokyo Smoke banners. Tweed is a
globally recognized cannabis brand which has built a large and
loyal following by focusing on quality products and meaningful
customer relationships.
From our historic public listing on the Toronto Stock Exchange
and New York Stock Exchange to our international expansion, pride
in advancing shareholder value through leadership is engrained in
all we do at Canopy Growth. Canopy Growth has established
partnerships with leading sector names including cannabis icons
Snoop Dogg and Seth Rogen, breeding
legends DNA Genetics and Green House Seeds, as well as lifestyle
guru Martha Stewart and Fortune 500
alcohol leader Constellation Brands, to name but a few. For more
information visit www.canopygrowth.com.
Notice Regarding Forward Looking Statements
This press
release contains "forward-looking statements" and "forward-looking
information" within the meaning of applicable U.S. and Canadian
securities laws (collectively, "forward-looking statements"), which
involve certain known and unknown risks and uncertainties.
Forward-looking statements predict or describe our future
operations, business plans, business and investment strategies and
the performance of our investments. These forward-looking
statements are generally identified by their use of such terms and
phrases as "intend," "goal," "strategy," "estimate," "expect,"
"project," "projections," "forecasts," "plans," "seeks,"
"anticipates," "potential," "proposed," "will," "should," "could,"
"would," "may," "likely," "designed to," "foreseeable future,"
"believe," "scheduled" and other similar expressions. You are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date the statement was made.
Forward–looking statements are necessarily based upon a number of
estimates and assumptions that, while considered reasonable by
management, are inherently subject to significant business,
economic and competitive risks, financial results, results,
performance or achievements expressed or implied by those
forward–looking statements and the forward–looking statements are
not guarantees of future performance. Accordingly, there are or
will be important factors that could cause actual outcomes or
results to differ materially from those indicated in these
statements. A discussion of some of the material factors applicable
to Canopy Growth Corporation ("Canopy") can be found under the
section entitled "Risk Factors" in Canopy's Annual Report on Form
10-K for the year ended March 31,
2020, filed with the Securities and Exchange Commission and
with applicable Canadian securities regulators, as such factors may
be further updated from time to time in its periodic filings with
the Securities and Exchange Commission and with applicable Canadian
securities regulators, which can be accessed at
www.sec.gov/edgar and www.sedar.com, respectively. These
factors should not be construed as exhaustive and should be read in
conjunction with the other cautionary statements that are included
in this press release and in the filings. Any forward–looking
statement included in this press release is made as of the date of
this press release and, except as required by law, Canopy disclaims
any obligation to update or revise any forward– looking statement.
Readers are cautioned not to put undue reliance on any
forward–looking statement. Forward-looking statements contained in
this press release are expressly qualified by this cautionary
statement.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/canopy-growth-to-move-us-stock-exchange-listing-to-nasdaq-301166027.html
SOURCE Canopy Growth Corporation